Valuation: Doxa AB

Market Cap 448M 46.86M 40.62M 38.08M 34.72M 65.33M 4.47B 66.38M 175M 2.24B 176M 172M 7.47B P/E 2024
-0.38x
P/E 2025 -1.69x
Enterprise Value 1.95B 204M 177M 166M 151M 284M 19.44B 289M 761M 9.73B 765M 748M 32.47B EV / Sales 2024
290x
EV / Sales 2025 102x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-2.01%
1 week-2.29%
Current month-4.61%
1 month-7.95%
3 months-13.98%
6 months-12.32%
Current year-22.39%
1 week 0.34
Extreme 0.3395
0.35
1 month 0.34
Extreme 0.3395
0.39
Current year 0.34
Extreme 0.3395
0.46
1 year 0.34
Extreme 0.3395
0.58
3 years 0.32
Extreme 0.32
4.02
5 years 0.32
Extreme 0.32
18.4
10 years 0.32
Extreme 0.32
18.4
Manager TitleAgeSince
Chief Executive Officer 52 2024-10-09
Director of Finance/CFO - 2026-04-27
Director TitleAgeSince
Chairman 66 2023-12-31
Director/Board Member 62 2025-04-28
Director/Board Member 63 2025-04-28
Date Insider Type Main position Quantity % Market Cap.
7/14/26 Buy 100,000 0.0078%
2/28/26 Buy 100,000 0.0078%
1/1/26 Buy

Chairman

1,969,790 0.1532%
Change 5-day change 1-year change 3-year change Capi.($)
-2.01%-2.29%-31.29%-91.56% 46.86M
-1.11%+0.87%+19.75%+27.56% 43.43B
+0.41%+4.39%+5.61%+2.88% 31.01B
-0.76%-4.20%+17.62%+112.75% 27.94B
-0.89%-3.62%-23.95%+62.03% 26.9B
+0.17%-4.30%-5.93%+45.51% 24.61B
-7.32%-4.86%+17.37%+4.21% 21.45B
0.00%-2.16%-34.27%-63.17% 20.93B
-0.91%-3.43%+12.17%+83.21% 19.77B
+0.07%+2.66%-5.80%-21.48% 18.8B
Average -1.22%-0.67%-2.87%+16.19% 23.49B
Weighted average by Cap. -1.05%-0.30%+2.21%+30.78%

Financials

2024 2025
Net sales 15.5M 1.62M 1.4M 1.32M 1.2M 2.26M 155M 2.29M 6.05M 77.4M 6.08M 5.95M 258M 20.3M 2.12M 1.84M 1.72M 1.57M 2.96M 202M 3.01M 7.93M 101M 7.97M 7.79M 338M
Net income -1.72B -180M -156M -146M -133M -251M -17.19B -255M -673M -8.61B -676M -662M -28.71B -335M -35.06M -30.39M -28.48M -25.97M -48.87M -3.35B -49.65M -131M -1.67B -132M -129M -5.59B
Net Debt 3.56B 372M 323M 303M 276M 519M 35.55B 528M 1.39B 17.79B 1.4B 1.37B 59.36B 1.5B 157M 136M 127M 116M 219M 14.97B 222M 586M 7.49B 589M 576M 25B
Logo Doxa AB
Doxa AB is a Sweden-based company which develops products based on bio-active ceramics. The Company develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
Employees
26
Date Price Change Volume
26-08-13 SEK 0.3415 -2.01% 262,866
26-08-12 SEK 0.3485 +1.90% 49,325
26-08-11 SEK 0.3420 -1.30% 157,886
26-08-10 SEK 0.3465 -1.00% 94,290
26-08-07 SEK 0.3500 +0.14% 279,661
  1. Stock Market
  2. Stocks
  3. DOXA Stock